Efficacy of sulfadoxine-pyrimethamine, amodiaquine, and sulfadoxine-pyrimethamine-amodiaquine combination for the treatment of uncomplicated falciparum malaria in the urban and suburban areas of Brazzaville (Congo)

Acta Tropica

Volumn 103, Issue 3, 2007, Pages 163-171

  Ndounga, Mathieu ^a   Mayengue, Pembe Issamou ^b   Tahar, Rachida ^c   Casimiro, Prisca N ^a   Matondo Maya, Davy W ^b   Miakassissa Mpassi, Valentine ^d   Malonga, David A ^d   Nsonde Ntandou, Freddy ^a   Mallanda, Godefroy ^e   Ringwald, Pascal ^f   Basco, Leonardo K ^c   Ntoumi, Francine ^b  

^a Centre d'Etudes sur les Ressources Végétales   (Congo)

^b Medical Unity Research   (Gabon)

^c Laboratoire de Recherche sur le Paludisme Yaounde   (Cameroon)

^d Centre hospitalier de Makélékélé   (Congo)

^e MINISTÈRE DE LA SANTÉ   (Congo)

^f WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Chloroquine; Clinical study; Drug combinations; Drug resistance; Plasmodium falciparum

Indexed keywords

AMODIAQUINE; FANSIDAR;

ANTIMALARIAL AGENT; DISEASE TREATMENT; DRUG RESISTANCE; MALARIA; POLYMERASE CHAIN REACTION; PROTOZOAN; QUININE; REPLACEMENT; URBAN AREA; WORLD HEALTH ORGANIZATION;

ARTICLE; COMBINATION CHEMOTHERAPY; CONFIDENCE INTERVAL; CONGO; CONTROLLED STUDY; DRUG EFFICACY; DRUG TREATMENT FAILURE; FOLLOW UP; GAMETOCYTE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MONOTHERAPY; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRESCHOOL CHILD; SINGLE DRUG DOSE; SUBURBAN AREA; TREATMENT RESPONSE; URBAN POPULATION; WORLD HEALTH ORGANIZATION;

AMODIAQUINE; ANTIMALARIALS; CARRIER STATE; CHILD, PRESCHOOL; CONGO; DNA, PROTOZOAN; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INFANT; MALARIA, FALCIPARUM; MALE; PYRIMETHAMINE; SULFADOXINE; TREATMENT OUTCOME;

AFRICA; BRAZZAVILLE; CENTRAL AFRICA; CONGO; SUB-SAHARAN AFRICA;

ARTESUNATE; PLASMODIUM FALCIPARUM;

EID: 34548154267     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actatropica.2007.06.002     Document Type: Article

References (33)

1. Adjuik M., Agnamey P., Babiker A., Borrmann S., Brasseur P., Cisse M., Cobelens F., Diallo S., Faucher J.F., Garner P., Gikunda S., Kremsner P.G., Krishna S., Lell B., Loolpapit M., Matsiegui P.B., Missinou M.A., Mwanza J., Ntoumi F., Olliaro P., Osimbo P., Rezbach P., Some E., and Taylor W.R. Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised multicentric trial. Lancet 359 (2002) 1365-1372
2. Aubouy A., Bakary M., Keundjian A., Mbomat B., Makita J.R., Migot-Nabias F., Cot M., Le Bras J., and Deloron P. Combination of drug level measurement and parasite genotyping data for improved assessment of amodiaquine and sulfadoxine-pyrimethamine efficacies in treating Plasmodium falciparum malaria in Gabonese children. Antimicrob. Agents Chemother. 47 1 (2003) 231-237
3. Bakyaita N., Dorsey G., Yeka A., Banek K., Staedke S.G., Kamya M.R., Talisuna A., Kironde F., Nsobya S., Kilian A., Reingold A., Rosenthal P.J., and Wabwire-Mangen F. Sulfadoxine-pyrimethamine plus chloroquine or amodiaquine for uncomplicated falciparum malaria: a randomized, multisite trial to guide national policy in Uganda. Am. J. Trop. Med. Hyg. 72 5 (2005) 573-580
4. Basco L.K., Same-Ekobo A., Ngane V.F., Ndounga M., Metoh T., Ringwald P., and Soula G. Therapeutic efficacy of sulfadoxine-pyrimethamine, amodiaquine and the sulfadoxine-pyrimethamine-amodiaquine combination against uncomplicated Plasmodium falciparum malaria in young children in Cameroon. Bull. World Health Organ. 80 7 (2002) 538-545
5. Basco L.K., Rachida, Tahar, and Ascalante A. Molecular epidemiology of malaria in Cameroon. XVIII. Polymorphisms of Plasmodium falciparum merozoite surface antigene-2 in isolates from symptomatic patients. Am. J. Trop. Med. Hyg. 70 3 (2004) 238-244
6. Basco L.K., Ngane V.F., Ndounga M., Same-Ekobo A., Youmba C., Okalla Obodo T., and Soula G. Molecular epidemiology of malaria in Cameroon. XXII. Baseline therapeutic efficacy of chloroquine, Amodiaquine and sulfadoxine-pyrimethamine in children before national drug policy change. Am. J. Trop. Med. Hyg. 75 3 (2006) 388-395
7. Brandicourt O., Carme B., Gay F., Turk P., and Gentilini M. Widespray "in vitro" resistance to chloroquine of Plasmodium falciparum in the Congo. Trop. Med. Parasitol. 42 (1991) 55-59
8. Carme B., Benthein F., Moudzeo H., Mbitsi A., and Madzou G. Chimiorésistance de Plasmodium falciparum au Congo. 1-Etude "in vivo" après 10 et 25 mg/kg de chloroquine (235 tests). Bull. Soc. Pathol. Exot. 79 (1986) 490-502
9. Carme B., Moudzeo H., Mbitsi A., Sathounkazi C., Ndounga M., Brandicourt O., Gay F., and Le Bras J. La chimiorésistance médicamenteuse de Plasmodium falciparum au Congo. Bilan des enquêtes réalisées de 1985 à 1989. Bull. Soc. Pathol. Exot. 83 (1990) 228-241
10. Carme B., Moudzeo H., Mbitsi A., Ndounga M., and Samba G. Stabilisation of drug resistance (chloroquine and amodiaquine) of Plasmodium falciparum in semi-immune population in the Congo. J. Infect. Dis. 164 (1991) 348-437
11. Carme B., Gay F., Chandenier J., Ndounga M., Ciceron L., Ebikili J.B., Schmith J.L., and Gentilini M. Unexpected trend in chemosensitivity of Plasmodium falciparum in Brazzaville, Congo. Lancet 338 (1991) 582-583
12. Carme B., Ndounga M., Kissila A.M., Samba G., and Baya Tsika N. Niveau de chloroquinorésistance inchangé (Plasmodium falciparum) chez l'enfant semi-immun depuis 1986 à Brazzaville. Bull. Soc. Path. Exot. 91 2 (1998) 164-166
13. Chandenier J., Ndounga M., Carme B., Gay F., Mbitsi A., Hayette M.P., Stanghelini A., and Gentilini M. Chimiosensibilité in vivo et in vitro de Plasmodium falciparum à Brazzaville (Congo). Cahiers Santé 5 (1995) 25-29
14. Checchi F., Kamara S., Williams A., Morineau G., Wurie A.R., Hora B., Lamotte N., Baerwaldt T., Heinzelmann A., Danks A., Pinoges L., Oloo A., Durand R., Ranford-Cartwright L., and Smet M. Evidence basis for antimalarial policy change in Sierra Leone: five in vivo efficacy studies of chloroquine, sulphadoxine-pyrimethamine and amodiaquine. Trop. Med. Int. Health 10 2 (2005) 146-153
15. Gasasira A.F., Dorsey G., Nzarubara B., Staedke S.G., Nassali A., Rosenthal P.J., and Kamya M.R. Comparative efficacy of aminoquinoline-antifolate combinations for the treatment of uncomplicated falciparum malaria in Kampala, Uganda. Am. J. Trop. Med. Hyg. 68 2 (2003) 125-136
16. Kazadi W.M., Vong S., Makina B.N., Mantshumba J.C., Kabuya W., Kebela B.I., and Ngimbi N.P. Assessing the efficacy of chloroquine and sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum malaria in the Democratic Republic of Congo. Trop. Med. Int. Health 8 10 (2003) 868-875
17. Mayengue P.I., Ndounga M., Davy M.M., Tandou N., and Ntoumi F. In vivo chloroquine resistance of the pfcrt codon 76 mutation in Plasmodium falciparum isolates from the Republic of Cong. Acta Trop. 95 3 (2005) 219-225
18. Menard D., Djalle D., and Talarmin A. Efficacy of chloroquine, amodiaquine, sulfadoxine-pyrimethamine, chloroquine-sulfadoxine-pyrimethamine combination, and amodiaquine-sulfadoxine-pyrimethamine combination in Central African children with non complicated malaria. Am. J. Trop. Med. Hyg. 72 5 (2005) 581-585
19. Nosten F., and Ashley E. The detection and treatment of Plasmodium falciparum malaria: time for change. J. Postgrad. Med. 50 1 (2004) 35-39
20. Nsimba B., Malonga D.A., Mouata A.M., Louya F., Kiori J., Malanda M., Yocka D., Oko-Ossho J., Ebata-Mongo S., and Le Bras J. Efficacy of sulfadoxine/pyrimethamine in the treatment of uncomplicated Plasmodium falciparum malaria in Republic of Congo. Am. J. Trop. Med. Hyg. 70 2 (2004) 133-138
21. Ntoumi F., Ngoundou-Landji J., Lekoulou F., Luty A., Deloron P., and Ringwald P. Site-based study on polymorphism of Plasmodium falciparum MSP-1 and MSP-2 genes in isolates from two villages in Central Africa. Parasitologia 42 (2000) 197-203
22. Oduro A.R., Anyorigiya T., Hodgson A., Ansah P., Anto F., Ansah N.A., Atuguba F., Mumuni G., and Amankwa J. A randomized comparative study of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated malaria in Ghana. Trop. Med. Int. Health 10 3 (2005) 279-284
23. Olliaro P.L., and Taylor W.R. Developing artemisinin based drug combinations for the treatment of drug resistant falciparum malaria: a review. J. Postgrad. Med. 50 1 (2004) 40-44
24. Rwagacondo C.E., Niyitegeka F., Sarushi J., Karema C., Mugisha V., Dujardin J.C., van Overmeir C., van der Ende J., and D'Alessandro U. Efficacy of amodiaquine alone and combined with sulfadoxine-pyrimethamine and of sulfadoxine-pyriméthamine combined with artesunate. Am. Trop. Med. Hyg. 68 6 (2003) 743-747
25. Soula, G., Ndounga, M., Foumane, V., Ollivier, G., Youmba, J.C., Basco, L., Boudin, C., Same-kobo, A., Ringwald, P., 2000. Bilan de la résistance de Plasmodium falciparum à la chloroquine au Cameroun et alternatives thérapeutiques. Bull. Liais. doc OCEAC 33 (4):13-22.
26. Staedke S.G., Mpimbaza A., Kamya M.R., Nzarubara B.K., Dorsey G., and Rosenthal P.J. Combination treatments for uncomplicated falciparum malaria in Kampala, Uganda: randomised clinical trial. Lancet 27 9449 (2004) 1922-1933 364
27. Tjitra E., Supriano S., and Anstey N.M. Higher gametocyte prevalence following failure of treatment of Plasmodium falciparum malaria with sulfadoxine-pyrimethamine and the combination of chloroquine plus sulfadoxine-pyrimethamine: implication for progression of antifolate resistance. Trans. R. Soc. Trop. Med. Hyg. 96 (2002) 234-237
28. Trape J.F. Malaria and urbanization in central Africa: the example of Brazzaville. Part II. Results of entomological surveys and epidemiological analysis. Trans. R. Soc. Trop. Med. Hyg. 81 Suppl. 2 (1987) 10-18
29. Trape J.F., Pison G., Preziosi M.P., Enel C., Desgrees du Lou A., Delauney V., Samb Badara B., Lagarde E., Molez J.F., and Simondon F. Impact of chloroquine resistance on malaria mortality. C.R. Acad. Sci. III 321 (1998) 689-697
30. Von Seidlein L., Melligan P., Pinder M., et al. Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambia children: a double-blind, randomised, controlled trial. Lancet 355 (2000) 352-365
31. World Heath Organization, 1996. Assessment of therapeutic efficacy for uncomplicated falciparum malaria in areas with intense transmission. World Heath Organization, Geneva. WHO/MAL/96.1077.
32. World Health Organisation, 2001. Antimalarial drug combination therapy. Report of a WHO Technical Consultation. WHO/CDS/RBM/2001.35.
33. World Health Organisation, 2003. Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria. WHP/HTM/RBM/2003.50.